Scorpius Holdings announces cost optimization including 28% headcount reduction

Scorpius Holdings (SCPX) provided a corporate update highlighting key strategic initiatives, including cost optimization measures expected to yield over $6 million in annualized savings and the Company’s exploration of opportunities to expand operations into Southeast Asia through a potential biomanufacturing presence in Malaysia. Scorpius has launched a strategic restructuring initiative designed to streamline operations, improve capital efficiency, and position the Company for long-term sustainable growth. This initiative includes a 28% reduction in headcount and the realignment of select non-core expenditures. These actions are expected to generate over $6 million in annualized cost savings while preserving the Company’s ability to deliver high-quality services to its client base. As part of its international business strategy, Scorpius is seeking to establish operations in Malaysia focused on delivering halal-compliant biomanufacturing and CDMO services. The Company is in preliminary discussions with key Malaysian stakeholders and regulatory authorities to explore the formation of a Malaysian subsidiary that would support regional and global distribution of biologics manufactured in accordance with halal standards. This initiative seeks to address a critical unmet need within the 2-billion-person global Muslim population, which remains significantly underserved in access to halal-certified biopharmaceutical products. Scorpius believes that its differentiated approach could meet the growing demand across Southeast Asia and other Muslim-majority markets. Scorpius has strengthened its Board of Directors with the appointment of Tan Sze Thuan, a prominent Malaysian entrepreneur. Mr. Tan is the Founder and Chief Executive Officer of World Total Logistics. Scorpius continues to serve clients in biologics manufacturing, process development, and analytical services. The Company believes that expanding these capabilities into Southeast Asia-while embedding halal standards from the ground up-could unlock access to new global markets and serve critical healthcare needs in a culturally aligned and commercially scalable manner. At the same time, the Company continues to explore a variety of potential strategic alternatives aimed at maximizing shareholder value.